THEMIS2 and thyroid gland carcinoma: THEMIS2 may serve as a novel marker for immune infiltration in thyroid cancer by activating the p53 and JAK-STAT signaling pathways, inhibiting T-cell activation, and facilitating the occurrence and progression of thyroid cancer.